Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Cancer Cytopathol. 2012 Apr 25;120(2):111-6. doi: 10.1002/cncy.20192. Epub 2011 Sep 14.

The atypia of undetermined significance/follicular lesion of undetermined significance:malignant ratio: a proposed performance measure for reporting in The Bethesda System for thyroid cytopathology.

Author information

  • 1Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115, USA. jkrane@partners.org

Abstract

BACKGROUND:

The Bethesda System (TBS) for reporting thyroid cytopathology introduced the atypia of undetermined significance/follicular lesion of undetermined significance (AUS) category, but did not provide adequate guidance for the appropriate use of this diagnosis. In the current study, the authors sought to identify an appropriate measure for AUS use based on experience to date with TBS.

METHODS:

The authors reviewed 8 series, including their own laboratory experiences, with a total of 30,466 thyroid aspirates classified within TBS.

RESULTS:

The median AUS rate was 9.9% with a range of 3.0% to 18.0%. Use of the individual diagnostic categories within TBS varied up to 12.7-fold. The ratio of "suspicious for follicular neoplasm" plus "suspicious for malignancy" to "malignant" (M) diagnoses varied the least (1.8-fold). The AUS:M ratio provided a suitable measure of assessing AUS use, with a median ratio of 2.0 and a range of 0.5 to 4.9.

CONCLUSIONS:

Based on available studies, an AUS:M ratio of 1.0 to 3.0 is recommended. AUS:M ratios > 3.0 are likely because of overdiagnosis of AUS or underdiagnosis of M. AUS:M ratios < 1.0 are mostly due to low AUS rates, at the likely expense of sensitivity.

Copyright © 2011 American Cancer Society.

PMID:
21919213
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for John Wiley & Sons, Inc.
    Loading ...
    Write to the Help Desk